In addition to presenting the industry's novelties, FCE Pharma offered unprecedented experiences to its more than 18,500 visitors.
"It is part of our DNA to surprise the market. We seek to evolve successful initiatives, bet on novelties that can improve the visitor experience and boost market development," explained João Paulo Picolo, CEO of NürnbergMesse Brasil. "We received a very positive feedback about the 2019 investments and we are very proud, especially because it comes from a highly qualified audience," he added.
